FDA Removes Pregnancy Category C Warning From Certain MS Medications
Other NEWS
- 240 P
Novartis update on FDA review of ofatumumab, a self-administered, targeted B-cell therapy for patients with relapsing multiple sclerosis
RECENT POSTS Basel, June 2, 2020 — Novartis today announced that it has received notice from the US Food and Drug Admin ... - 240 PPediatric Multiple Sclerosis Severity Score in a Large U.S. Cohort
RECENT POSTS ... - 240 P
Why an MRI Is Used to Diagnose Multiple Sclerosis
RECENT POSTS MRI and MS Multiple sclerosis (MS) is a condition in which the body’s immune system attacks the protective c ... - 240 P
Innovations in MS Care and Treatment
RECENT POSTS Click HERE to Subscribe for the MS Beacon Newsletter Event Date: October 12, 2019 { a (3) Speaker presentation and ... - 240 PChina’s Post-Pandemic Water Woes
RECENT POSTSFew places have suffered more from the COVID-19 pandemic than southern China, the region where the novel coronavirus wa ...
0 Comments: